Advertisment

The Economic Impact of Innovation in Women's Health Care

author-image
Mason Walker
New Update
NULL

The Economic Impact of Innovation in Women's Health Care

Advertisment

The Cost of Innovation in Women's Health

Advertisment

The cost of innovation and devices in women's health is a significant concern, as it may outstrip their reimbursement, leading to a potential inability to offer them in the future. This could result in a lack of industry investment and further lag in women's health advancements. However, addressing this gap could generate a considerable economic benefit.

Economic Benefit of Addressing Women's Health Gap

According to a report by the World Economic Forum and McKinsey, addressing the gap in women's health could generate one trillion in global economic benefit by 2040. Most of this potential comes from women of working age. The top 10 gynaecological diseases contribute to more than 50% of the economic impact associated with closing the women's health gap. The World Economic Forum has launched the Global Alliance for Women's Health to bridge this gap, with 42 organizations joining the alliance and 55 million pledged toward the improvement of women's health.

Advertisment

Innovations in Women's Health

Three innovations that can potentially transform women's health include one-shot HPV vaccines, self-administering family planning solutions, and a plastic pad for diagnosing postpartum blood loss. These innovations have the potential to save hundreds of thousands of lives of women dying in childbirth. For every dollar invested in women's health, there is a 3% return to society.

Understanding Women's Health Issues

Advertisment

Understanding women’s health issues, including maternal mental and behavioral health, insurance coverage, costs of care, transgender health, health policy, obstetrical and gynecological care, and prenatal care, is crucial in this context. It is equally vital to consider the cost-effectiveness of innovations and devices in women's health.

Wearable Reproductive Health Technology

Wearable reproductive health technology for tracking menstrual cycles and fertility in women is another promising innovation. These devices effectively predict different stages of the menstrual cycle, including the fertile window, ovulation, and menstruation. However, more research is needed to evaluate consumer perspectives, ethical issues around privacy of digital data, and validation of the research findings.

Advertisment

Gene-Specific Prevention Strategies

The cost-effectiveness of gene-specific prevention strategies for ovarian and breast cancer among women with pathogenic variants in individual cancer susceptibility genes is another important area. A decision analytic Markov model found undergoing both risk reducing mastectomy and risk reducing salpingo oophorectomy was most cost effective for individuals carrying BRCA1, BRCA2, PALB2, RAD51C, RAD51D, or BRIP1 pathogenic variants. This strategy can prevent numerous ovarian and breast cancer cases and deaths.

Conclusion

While the cost of innovations and devices in women's health is a concern, their potential benefits cannot be overlooked. These advancements can significantly improve women's health and generate substantial economic benefits. The key is to balance the cost of these innovations with their potential health and economic returns.

Advertisment
Chat with Dr. Medriva !